TRICARICO, Domenico
 Distribuzione geografica
Continente #
NA - Nord America 9.587
AS - Asia 3.773
EU - Europa 3.267
SA - Sud America 990
AF - Africa 146
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
AN - Antartide 1
Totale 17.774
Nazione #
US - Stati Uniti d'America 9.431
SG - Singapore 1.515
IT - Italia 1.109
CN - Cina 968
BR - Brasile 768
SE - Svezia 443
HK - Hong Kong 435
RU - Federazione Russa 372
DE - Germania 267
FR - Francia 244
VN - Vietnam 235
UA - Ucraina 209
GB - Regno Unito 198
FI - Finlandia 195
IN - India 138
BD - Bangladesh 105
CA - Canada 80
AR - Argentina 66
IQ - Iraq 53
ID - Indonesia 48
CI - Costa d'Avorio 47
MX - Messico 40
TR - Turchia 39
PK - Pakistan 36
EC - Ecuador 35
BE - Belgio 33
CO - Colombia 32
ES - Italia 32
PL - Polonia 30
VE - Venezuela 30
ZA - Sudafrica 28
JP - Giappone 25
CL - Cile 22
IE - Irlanda 20
NL - Olanda 20
SA - Arabia Saudita 19
UZ - Uzbekistan 18
PH - Filippine 15
CZ - Repubblica Ceca 14
MA - Marocco 14
AT - Austria 13
TN - Tunisia 13
UY - Uruguay 13
KR - Corea 11
LT - Lituania 11
NP - Nepal 11
KZ - Kazakistan 10
RS - Serbia 10
MY - Malesia 9
AE - Emirati Arabi Uniti 8
JO - Giordania 8
PE - Perù 8
PY - Paraguay 8
EG - Egitto 7
IR - Iran 7
KE - Kenya 7
PA - Panama 7
TW - Taiwan 7
AZ - Azerbaigian 6
BA - Bosnia-Erzegovina 6
BO - Bolivia 6
CH - Svizzera 6
CR - Costa Rica 6
DZ - Algeria 6
NO - Norvegia 6
OM - Oman 6
AU - Australia 5
IL - Israele 5
SN - Senegal 5
TH - Thailandia 5
AM - Armenia 4
BG - Bulgaria 4
BH - Bahrain 4
ET - Etiopia 4
HN - Honduras 4
HR - Croazia 4
JM - Giamaica 4
SV - El Salvador 4
AL - Albania 3
DK - Danimarca 3
KW - Kuwait 3
LB - Libano 3
NG - Nigeria 3
PT - Portogallo 3
QA - Qatar 3
RO - Romania 3
TT - Trinidad e Tobago 3
A1 - Anonimo 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GE - Georgia 2
HU - Ungheria 2
KG - Kirghizistan 2
LK - Sri Lanka 2
PS - Palestinian Territory 2
AO - Angola 1
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
Totale 17.745
Città #
Fairfield 1.018
Ashburn 951
Singapore 828
Woodbridge 781
Chandler 710
San Jose 483
Jacksonville 450
Seattle 440
Houston 432
Hong Kong 424
Ann Arbor 395
Milan 394
Cambridge 367
Nyköping 361
Wilmington 334
Beijing 291
Dallas 198
Bari 168
Los Angeles 147
Lawrence 143
Roxbury 143
Nanjing 139
Lauterbourg 135
New York 126
Rome 122
Des Moines 94
Princeton 85
Ho Chi Minh City 83
Boardman 79
Santa Clara 79
Helsinki 77
Inglewood 69
São Paulo 62
San Diego 55
London 52
Abidjan 47
Buffalo 44
Chicago 42
Shenyang 40
Munich 39
Brooklyn 38
Council Bluffs 35
Frankfurt am Main 35
Figino 34
Hanoi 34
Nanchang 34
Brussels 33
Rio de Janeiro 32
Jakarta 31
Dong Ket 30
Moscow 30
Jiaxing 28
Baghdad 27
Columbus 27
Montreal 27
Shanghai 27
Changsha 25
Tianjin 25
Warsaw 25
Belo Horizonte 23
San Francisco 23
Phoenix 22
Tokyo 20
Atlanta 19
Denver 19
Dublin 19
Hebei 19
Johannesburg 19
Toronto 19
Turin 19
Orem 18
Guangzhou 17
Poplar 17
Chennai 16
Mexico City 16
Dearborn 15
Dhaka 15
Paris 15
Redwood City 15
Brasília 14
Manchester 14
Pune 14
Zhengzhou 14
Lahore 13
Medellín 13
Mumbai 13
Nuremberg 13
Quito 13
Stockholm 13
The Dalles 13
Brno 12
New Delhi 12
Norwalk 12
Ribeirão Preto 12
Tashkent 12
Falkenstein 11
Jinan 11
Montevideo 11
Naples 11
North Bergen 11
Totale 12.131
Nome #
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 245
A novel injectable formulation of 6-Fluoro-L-DOPA imaging agent for diagnosis of neuroendocrine tumors and Parkinson’s disease 233
ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force 227
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 216
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 202
Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options 201
Antiproliferative effects of neuroprotective drugs targeting big Ca2+-activated K+ (BK) channel in the undifferentiated neuroblastoma cells 194
Carbonic anhydrase inhibitors ameliorate the symptoms of hypokalaemic periodic paralysis in rats by opening the muscular Ca2+-activated-K+ channels 193
Acetazolamide prevents vacuolar myopathy in skeletal muscle of K+-depleted rats 193
Cell Cycle Regulation by Ca2+-Activated K+ (BK) Channels Modulators in SH-SY5Y Neuroblastoma Cells 186
New Azepino[4,3-b]indole derivatives as nanomolar selective inhibitors of human butyrylcholinesterase showing protective effects against NMDA-induced neurotoxicity 185
Alginate-Based Hydrogel Containing Minoxidil/Hydroxypropyl-β-Cyclodextrin Inclusion Complex for Topical Alopecia Treatment 181
Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis 179
Zoledronic acid modulation of TRPV1 channel currents in osteoblast cell line and native rat and mouse bone marrow-derived osteoblasts: Cell proliferation and mineralization effect 173
Bridging repair of the abdominal wall in a rat experimental model. Comparison between uncoated and polyethylene oxide-coated equine pericardium meshes 169
Acetazolamide opens the muscular K(Ca)2+ channel: A novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis 165
Reduced expression of Kir6.2/SUR2A subunits explains KATP deficiency in K+-depleted rats 164
Recent advances in the pathogenesis and drug action in periodic paralyses and related channelopathies 163
Acetazolamide opens the muscular KCa2+ channel: a novel mechanism of action that may explain the therapeutic effect of the drug in the hypokalemic periodic paralysis 162
Risk of myopathy in patients in therapy with statins: Identification of biological markers in a pilot study 161
Aging and chloride channel regulation in rat fast-twitch muscle fibres 160
Molecular modeling of antibodies for the treatment of TNFα-related immunological diseases 157
Oxytocin/Osteocalcin/IL-6 and NGF/BDNF mRNA Levels in Response to Cold Stress Challenge in Mice: Possible Oxytonic Brain-Bone-Muscle-Interaction 156
The biophysical and pharmacological characteristics of skeletal muscle ATP-Sensitive K+ channels are modified in K+-depleted rat, an animal model of hypokalemic periodic paralysis 152
The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia 152
Nerve growth factor, brain-derived neurotrophic factor and osteocalcin gene relationship in energy regulation, bone homeostasis and reproductive organs analyzed by mrna quantitative evaluation and linear correlation analysis 151
The large conductance Ca2+ -activated K+ (BKCa) channel regulates cell proliferation in SH-SY5Y neuroblastoma cells by activating the staurosporine-sensitive protein kinases 150
Changes of chloride channel regulation in rat skeletal muscle during aging 146
Antimyotonic actions of new chiral sodium channel, blockers 145
Accelerated infliximab infusion: Safety, factors predicting adverse events, patients' satisfaction and cost analysis. A cohort study in IBD patients 143
Calcium-Activated K Channel Regulates Cell Viability in Hyperkalemic and Hypokalemic Conditions: Implication in the Neuromuscular Disoders 141
Molecular structure and function of big calcium-activated potassium channels in skeletal muscle: Pharmacological perspectives 141
Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+ - deficient rats 140
Thymidine Phosphorylase Expression and Microvascular Density Correlation Analysis in Canine Mammary Tumor: Possible Prognostic Factor in Breast Cancer 140
Effects of clofibric acid analogs on chloride channel conductance of rat skeletal muscle 140
Pharmacovigilance database search discloses ClC-K channels as a novel target of the AT1 receptor blockers valsartan and olmesartan 139
Carboxylic acids and chloride conductance in skeletal muscle: influence on the pharmacological activity induced by the chain substituents and the distance between the phenolic group and the carboxylic function in 4-chloro-phenoxy alkanoic acids 137
Single-dose extended-toxicity preclinical study on novel radiotracer formulations for use in the diagnosis of neuroendocrine tumor and neurodegenerative disorders 137
Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery 135
Commentary: A BK (Slo1) channel journey from molecule to physiology. 135
Calcium homeostasis is altered in skeletal muscle of spontaneously hypertensive rats cytofluorimetric and gene expression analysis 134
Atrophy and phenotype transition signaling exert opposite actions on the KATP channels of disused rat soleus muscle 133
Cold stress in mice requires Nerve Growth Factor activity in brown fat and increases Osteocalcin expression in bone 133
Pharmaceutical development of novel lactate-based 6-fluoro-L-DOPA formulations 132
Staurosporine Blocks the ATP-Sensitive K+ Channels and Induces Atrophy in Rodent Skeletal Muscles 129
Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type-dependent biophysical and pharmacological properties 129
Effects of Acetazolamide on alpha subunit of human BK channel expressed in HEK293 cells 128
A new benzoxazine compound blocks KATP channels in pancreatic beta cells: molecular basis for tissue selectivity in vitro and hypoglycaemic action in vivo 128
Molecular determinants for the activating/blocking actions of the 2H-1,4-benzoxazine derivatives, a class of potassium channel modulators targeting the skeletal muscle KATP channels 128
Splicing of the rSlo gene affects the molecular composition and drug response of Ca2+-activated K+ channels in skeletal muscle 128
Biophysical changes of skeletal muscle K-ATP channels in K+ depleted rats and pharmacological interventions. 126
Involvement of K(Ca2+)channels in the local abnormalities and hyperkalemia following the ischemia-reperfusion injury of rat skeletal muscle 126
Dual response of the KATP channels to staurosporine: a novel role of SUR2B, SUR1 and Kir6.2 subunits in the regulation of the atrophy in different skeletal muscle phenotypes 125
Ion channels in muscle and cardiac hereditary diseases: from gene dysfunction to pharmacological therapy 125
ALTERATIONS OF ELECTRICAL AND BIOCHEMICAL PARAMETERS OF ISCHEMIC AND REPERFUSED RAT SKELETAL-MUSCLE FIBERS 120
Taurine and skeletal muscle ion channels 119
Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides-induced atrophy in skeletal muscle 118
Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms. 117
Effects of Pleiotrophin Overexpression on Mouse Skeletal Muscles in Normal Loading and in Actual and Simulated Microgravity 117
Effects of mexiletine on ATP sensitive K+ channel of rat skeletal muscle fibres: a state dependent mechanism of action 116
Taurine and skeletal muscle disorders 116
Bisphosphonates Targeting Ion Channels and Musculoskeletal Effects 115
Different sulfonylurea and ATP sensitivity characterizes the juvenile and the adult form of K-ATP channel complex of rat skeletal muscle 115
Insulin modulation of ATP-sensitive K+ channel of rat skeletal muscle is impaired in the hypokalaemic state 115
Drugs targeting the metabolically regulated ATP-sensitive potassium channels and big calcium-activated potassium channels in skeletal muscles: Pharmacological perspectives and therapeutic use 115
Involvement of 3Na+/2K+ ATP-ase and Pi-3 kinase in the response of skeletal muscle ATP-sensitive K+ channels to insulin 114
Effects of taurine analogues on chloride channel conductance of rat skeletal muscle fibers: a structure-activity relationship investigation 114
Expression profile of NGF-BDNF and Osteocalcin genes in brain, bone, fat stores and reproductive organs 114
Osteocalcin interacts with Brain-derived Neurotrophic Factor, Nerve Growth Factor but not Oxytocin in the regulation of bone, energy, brain and reproductive functions. 114
Effects of high energy phosphates and l-arginine on the electrical parameters of ischemic-reperfused rat skeletal muscle fibers 114
Dualistic actions of cromakalim and new potent 2H-1,4-benzoxazine derivatives on the native skeletal muscle K(ATP) channel 113
Zoledronic acid as a novel dual blocker of KIR6.1/2-SUR2 subunits of ATP-sensitive K+ channels: Role in the adverse drug reactions 113
NGF-BDNF-Osteocalcin and oxytocin gene interaction in brain, bone, fat stores and reproductive organs 112
Developmental changes of membrane electrical properties of rat skeletal muscle fibers produced by prenatal exposure to carbon monoxide 112
ATP-sensitive Potassium Channel Subunits in Neuroinflammation: Novel Drug Targets in Neurodegenerative Disorders 111
Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis 110
Enantiomeric pairs of clofibric acid analogs produce opposite effects on chloride channel conductance in rat skeletal muscle 110
Approccio multi-target alla terapia medica dell’ipertrofia prostatica benigna 109
A stereospecific bindings site regulates the Cl- ion channel in rat skeletal muscle 109
An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function 108
Cysteine restores the activity of ATP-sensitive potassium channels of skeletal muscle fibers of aged rats 107
Biophysical and pharmacological characterization of K-ATP and BK channels of slow and fast rat skeletal muscle fibers 106
Taurine blocks ATP-sensitive potassium channels of rat skeletal muscle fibres interfering with the sulphonylurea receptor 106
ATP-sensitive K+ channels of skeletal muscle fibers from young adult and aged rats: Possible involvement of thiol-dependent redox mechanisms in the age-related modifications of their biophysical and pharmacological properties 104
Experimental evaluation of the effects of pravastatin on electrophysiological parameters of rat skeletal muscle 104
Effects of the antidiabetic drugs on the age-related atrophy and sarcopenia associated with diabetes type II 103
Analysis of the introduction in clinical practice of new oral anticoagulants in local health agency bt: Translation of the clinical trial data to a local health care area 103
Stereospecific effects of tocainide and its chiral derivatives on rat skeletal muscle sodium channel. 102
Phenotype-dependent functional and pharmacological properties of BK channels in skeletal muscle: Effects of microgravity 102
Specific binding of nicergoline on alpha1-like adrenoreceptor in the rat retina 102
Stereoselective interaction of tocainide and its chiral analogs with the sodium channels in human myoballs 102
Immunohistochemical, pharmacovigilance, and omics analyses reveal the involvement of ATP-sensitive K+ channel subunits in cancers: role in drug–disease interactions 101
The KATP channel is a molecular sensor of atrophy in skeletal muscle 101
PYRIMIDIN 3-OXIDE COMPOUNDS SUITABLE FOR THE TREATMENT OF PATHOLOGIES OF THE SKELETAL MUSCLE, IN PARTICULAR FOR THE TREATMENT OF THE HYPOKALEMIC PARALYSIS 100
ATP-DEPENDENT EFFECTS OF CROMAKALIM AND OF NEW SYNTHESIZED BENZOXAZINE DERIVATIVES ON MUSCLE KATP CHANNEL. 100
Structural nucleotide analogs are potent activators/inhibitors of pancreatic beta-cell KATP channels: an emerging mechanism supporting their use as anti-diabetic drugs. 100
Calcium activated K+ channel as a target of prompt-to-use drugs in neuromuscular disorders 99
Evaluation of short and long term cold stress challenge of nerve grow factor, brain-derived neurotrophic factor, osteocalcin and oxytocin mRNA expression in BAT, brain, bone and reproductive tissue of male mice using real-time PCR and linear correlation analysis 98
Consequences of SUR2[A478V] Mutation in Skeletal Muscle of Murine Model of Cantu Syndrome 98
Taurine and skeletal muscle ion channels 97
Totale 13.488
Categoria #
all - tutte 76.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.121


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.176 40 192 13 59 46 64 66 50 114 77 163 292
2022/20231.855 260 198 132 177 231 235 20 207 294 14 52 35
2023/2024703 37 124 42 60 101 138 14 40 25 27 18 77
2024/20252.660 105 45 181 97 90 222 260 278 109 136 358 779
2025/20265.847 782 299 403 567 697 281 678 167 578 489 210 696
2026/2027161 161 0 0 0 0 0 0 0 0 0 0 0
Totale 18.116